Advances in the pathophysiology, diagnosis, and management of celiac disease  BMJ. 2025;391:e081353
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41093604

Anticoagulation outcomes in cirrhotic patients with portal vein thrombosis: a tertiary center study  Postgraduate Medical Journal. 2025;101(1201):1166–1172
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40298249

Arrhythmias in Cronkhite-Canada Syndrome Internal Medicine. 2025;64(21):3117–3121
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40368782

Cause-specific mortality among Queensland people with cirrhosis, by cirrhosis aetiology and decompensation status, 2007-22: a retrospective cohort study  Medical Journal of Australia. 2025;223(9):473–483
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40931480

Clinical practice guidelines for hepatocellular carcinoma surveillance for people at high risk in Australia: summary of recommendations  Medical Journal of Australia. 2025;223(8):426–436
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40976940

Coexistence of Relapsing Polychondritis, Crohn’s Disease, and Pyoderma Gangrenosum Treated Successfully with Adalimumab: A Case Report and Literature Review  Internal Medicine. 2025;64(20):2971–2978
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40128993

Common Diseases in Clinical Cohorts - Not Always What They Seem  New England Journal of Medicine. 2025;393(16):1589–1598
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41124632

Delayed Hepatitis B Virus Reactivation at 33 Months after the Completion of Rituximab-based Chemotherapy  Internal Medicine. 2025;64(20):2966–2970
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40222940

Diagnosis and management of reactive infectious mucocutaneous eruption  Journal of Hospital Medicine. 2025;20(11):1212–1216
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40619921

Early-Onset Gastrointestinal Cancers: A Review  JAMA. 2025;334(15):1373–1385
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40674064

Helicobacter pylori Screening After Acute Myocardial Infarction: The Cluster Randomized Crossover HELP-MI SWEDEHEART Trial JAMA. 2025;334(13):1160–1169
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40887995

Idiopathic Interstitial Lung Disease with Positive Anti-Zo and Anti-Ro52/SSA1 Antibodies  Internal Medicine. 2025;64(20):2990–2994
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40189294

Impact of the FIB4 Index on Pre-sarcopenia in Patients with Metabolic-dysfunction Associated Steatotic Liver Disease  Internal Medicine. 2025;64(21):3078–3087
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40301034

Importance of Vaccine Adjuvants: A Comparative Study of Antibody Acquisition Rates and Levels Before and After Adjuvant Change in the Hepatitis B Vaccine  Internal Medicine. 2025;64(21):3103–3106
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41183895

Metachronous Occurrence of Mucosa-associated Lymphoid Tissue (MALT) Lymphoma in the Esophagus and Tonsillar Diffuse Large B-cell Lymphoma 18 Years After Helicobacter pylori Eradication for Gastric MALT Lymphoma  Internal Medicine. 2025;64(21):3111–3116
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40301035

Oral anticoagulation in patients with gastrointestinal bleeding and new-onset atrial fibrillation: A population-based registry-linkage study  Journal of Internal Medicine. 2025;298(5):450–463
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40985187

Perioperative camrelizumab plus rivoceranib versus surgery alone in patients with resectable hepatocellular carcinoma at intermediate or high risk of recurrence (CARES-009): a randomised phase 2/3 trial  Lancet. 2025;406(10515):2089–2099
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41125112

A Rare Case of Hughes-Stovin Syndrome Presenting with Ischemic Colitis Caused by an Arteriovenous Malformation  Internal Medicine. 2025;64(20):3066–3071
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40222941

Rheumatoid Arthritis That Developed in a Patient with Ulcerative Colitis During Adalimumab Therapy: A Case Report and Literature Review  Internal Medicine. 2025;64(21):3158–3162
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40301040

Targeting MASLD and MASH in the US Hispanic/Latino Population: A Review  JAMA Intern Med. 2025;185(11):1376–1386
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40982275

Things We Do for No Reason™: Teach caregivers reflux precautions  Journal of Hospital Medicine. 2025;20(11):1223–1225
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40598648

Two Cases of Esophageal Mucosal Damage Observed after Peroral Endoscopic Myotomy for Esophageal Motility Disorders Internal Medicine. 2025;64(20):2979–2984
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40189292